SANOFI INDIA LIMITED (SANOFI) financials
SANOFI INDIA LIMITED (SANOFI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]
- Market Cap: ₹6,776Cr.
- Current Price: ₹2,942
- Stock P/E: 19.8
- ROE: 43.0%
- ROCE: 57.5%
- Book Value: ₹359
- Dividend Yield: 2.55%
- 52W High / Low: ₹4,898/2,907
In Jun 2026, SANOFI INDIA LIMITED (SANOFI) reported sales ₹438 Cr and net profit ₹84 Cr.
Annual TTM: sales ₹1,805 Cr, net profit ₹324 Cr.
Shareholding: Promoters 60.40% (Jun 2026), FIIs 5.69% (Jun 2026), DIIs 19.87% (Jun 2026), Public 14.05% (Jun 2026), No. of Shareholders 80,005% (Jun 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 524 | 515 | 536 | 406 | 475 | 420 | 472 | 438 |
| Expenses | 404 | 397 | 364 | 311 | 341 | 330 | 330 | 322 |
| Operating Profit | 120 | 118 | 172 | 95 | 134 | 90 | 143 | 115 |
| OPM % | 23% | 23% | 32% | 23% | 28% | 22% | 30% | 26% |
| Other Income | 2 | 14 | 3 | 9 | -22 | 3 | 4 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 9 | 10 | 10 | 9 | 9 | 10 | 9 | 9 |
| Profit before tax | 113 | 122 | 165 | 94 | 102 | 83 | 138 | 112 |
| Tax % | 27% | 25% | 28% | 26% | 26% | 26% | 26% | 26% |
| Net Profit | 82 | 91 | 120 | 70 | 76 | 62 | 103 | 84 |
| EPS in Rs | 35.74 | 39.70 | 51.96 | 30.22 | 33.04 | 26.83 | 44.61 | 36.30 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,071 | 2,902 | 2,957 | 2,770 | 2,851 | 2,013 | 1,837 | 1,805 |
| Expenses | 2,403 | 2,186 | 2,194 | 2,066 | 2,047 | 1,522 | 1,346 | 1,323 |
| Operating Profit | 667 | 716 | 762 | 704 | 804 | 491 | 491 | 483 |
| OPM % | 22% | 25% | 26% | 25% | 28% | 24% | 27% | 27% |
| Other Income | 33 | 45 | 564 | 204 | 83 | 79 | -8 | -9 |
| Interest | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 100 | 82 | 67 | 42 | 40 | 37 | 37 | 36 |
| Profit before tax | 600 | 677 | 1,258 | 864 | 846 | 531 | 445 | 436 |
| Tax % | 31% | 29% | 25% | 28% | 29% | 22% | 27% | — |
| Net Profit | 414 | 478 | 944 | 621 | 603 | 414 | 327 | 324 |
| EPS in Rs | 180.09 | 207.65 | 410.61 | 269.83 | 262.26 | 179.78 | 142.04 | 140.78 |
| Dividend Payout % | 194% | 176% | 119% | 211% | 64% | 65% | 87% | — |
| Category | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 2,419 | 2,096 | 2,203 | 1,253 | 992 | 838 | 726 | 803 |
| Borrowings | 0 | 23 | 25 | 24 | 19 | 19 | 18 | 15 |
| Other Liabilities | 802 | 777 | 811 | 772 | 681 | 732 | 488 | 567 |
| Total Liabilities | 3,244 | 2,918 | 3,061 | 2,072 | 1,715 | 1,612 | 1,255 | 1,407 |
| Fixed Assets | 499 | 464 | 334 | 306 | 315 | 312 | 304 | 291 |
| CWIP | 17 | 10 | 13 | 24 | 16 | 18 | 12 | 19 |
| Investments | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Other Assets | 2,728 | 2,444 | 2,714 | 1,743 | 1,382 | 1,281 | 939 | 1,098 |
| Total Assets | 3,244 | 2,918 | 3,061 | 2,072 | 1,715 | 1,612 | 1,255 | 1,407 |
| Category | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 374 | 412 | 611 | 559 | 399 | 231 | 462 | 438 |
| Cash from Investing Activity | -73 | 66 | 276 | 631 | 651 | 36 | -178 | -11 |
| Cash from Financing Activity | -197 | -183 | -810 | -849 | -1,583 | -878 | -392 | -448 |
| Net Cash Flow | 104 | 295 | 78 | 341 | -533 | -612 | -109 | -21 |
| Free Cash Flow | 317 | 337 | 810 | 574 | 412 | 221 | 426 | 413 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 99% | 96% | 112% | 111% | 94% | 59% | 114% | 111% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% |
| FIIs | 5.78% | 5.64% | 5.58% | 5.61% | 5.57% | 5.55% | 5.65% | 5.69% |
| DIIs | 22.62% | 22.94% | 23.02% | 23.06% | 22.28% | 21.30% | 21.12% | 19.87% |
| Public | 11.20% | 11.04% | 11.01% | 10.94% | 11.75% | 12.75% | 12.84% | 14.05% |
| No. of Shareholders | 66,211 | 66,401 | 68,196 | 66,790 | 71,395 | 75,813 | 75,758 | 80,005 |
| Category | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 27 | 19 | 18 | 17 | 17 | 42 | 35 |
| Inventory Days | 154 | 127 | 107 | 110 | 125 | 202 | 186 | 127 |
| Days Payable | 110 | 100 | 93 | 105 | 109 | 89 | 151 | 79 |
| Cash Conversion Cycle | 65 | 54 | 33 | 22 | 33 | 130 | 77 | 83 |
| Working Capital Days | 18 | 35 | -8 | -20 | -19 | 24 | 17 | 7 |
| ROCE % | 29% | 28% | 32% | 35% | 41% | 71% | 49% | 58% |
Sanofi India Limited
₹6,776Cr.
₹2,942
₹4,898/2,907
19.8
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of SANOFI INDIA LIMITED (SANOFI)?
The reported market capitalisation for SANOFI INDIA LIMITED (SANOFI) is ₹6,776Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of SANOFI?
The current price shown for SANOFI INDIA LIMITED (SANOFI) on Fincrux is ₹2,942 with a 52-week high/low of ₹4,898/2,907.
What is the P/E ratio of SANOFI INDIA LIMITED (SANOFI)?
The stock P/E for SANOFI INDIA LIMITED (SANOFI) is 19.8 on Fincrux, with ROE at 43.0% and ROCE at 57.5%.
What were SANOFI latest quarterly results?
For Jun 2026, SANOFI INDIA LIMITED (SANOFI) reported sales ₹438 Cr and net profit ₹84 Cr (figures in ₹ crore unless noted).
What are SANOFI annual sales and net profit?
For TTM, SANOFI INDIA LIMITED (SANOFI) shows sales of ₹1,805 Cr and net profit of ₹324 Cr on the Fincrux profit & loss statement.
Who owns SANOFI INDIA LIMITED (SANOFI)?
Latest shareholding for SANOFI INDIA LIMITED (SANOFI) on Fincrux: Promoters 60.40% (Jun 2026), FIIs 5.69% (Jun 2026), DIIs 19.87% (Jun 2026), Public 14.05% (Jun 2026), No. of Shareholders 80,005% (Jun 2026).
Where can I find SANOFI INDIA LIMITED (SANOFI) financials?
SANOFI INDIA LIMITED (SANOFI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show SANOFI balance sheet and cash flow?
Yes. The SANOFI INDIA LIMITED (SANOFI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.